Product Information
ASPIRIN 325 MG TABLET is a generic product labeled by Cardinal Health, priced at $0.0164 per EA under NDC 70000025302. Its NADAC has been published 345 times since Dec 12, 2018.
Strength
325 mg/1
Manufacturer
Cardinal HealthNDC
70000025302
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
2/10/1996
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN 325 MG TABLET has been published 345 times since Dec 12, 2018, and over the history we have for it it has risen 64.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0164 per EA |
|---|---|
| All-time high | $0.0166 (Jul 10, 2024) |
| All-time low | $0.0096 (Apr 20, 2022) |
| 52-week high | $0.0164 |
| 52-week low | $0.0154 |
| Median price | $0.0120 |
| Average price | $0.0130 |
| Largest weekly change | -18.8% (Apr 19, 2023) |
| Weeks tracked | 345 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ASPIRIN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN 325 MG TABLET, manufactured by Cardinal Health, is $0.0164 per EA (NDC 70000025302), effective Aug 19, 2026.
How has the price of ASPIRIN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ASPIRIN 325 MG TABLET has risen 64.6%. It has been tracked across 345 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for ASPIRIN 325 MG TABLET?
Since Dec 12, 2018, the NADAC for ASPIRIN 325 MG TABLET has ranged from a low of $0.0096 (Apr 20, 2022) to a high of $0.0166 (Jul 10, 2024), with a median of $0.0120 per EA.
Are there cheaper alternatives to ASPIRIN 325 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ASPIRIN 325 MG TABLET, is $0.0121 per EA — about 27% below ASPIRIN 325 MG TABLET.
Who manufactures ASPIRIN 325 MG TABLET?
ASPIRIN 325 MG TABLET (NDC 70000025302) is labeled by Cardinal Health, and CMS classifies it as a generic product.